VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at EASL 2020

Looking back at the data from the CONSTANT study, its clear that the immunogenicity of the tri-antigenic vaccine, Sci-B-Vac, is significantly higher than that of the mono-antigenic vaccine, Engerix-B, said Dr. Finn.